You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CO-338

Showing 1 - 25 of 5,684
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Akashi, Hidaka, Tsukiji (Rucaparib)

Completed
  • Advanced Solid Tumor
  • Akashi, Hyogo, Japan
  • +2 more
May 16, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

Recruiting
  • Mesothelioma, Malignant
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust
Apr 6, 2022

Breast Cancer, Prostate Cancer, Ovarian Cancer Trial in Worldwide (Part 1, Dose Level 1 and Dose Level 2a: Ipatasertib, Part 1,

Completed
  • Breast Cancer
  • +2 more
  • Part 1, Dose Level 1 and Dose Level 2a: Ipatasertib
  • +3 more
  • San Marcos, California
  • +16 more
Jan 25, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +4 more
  • Clovis, California
  • +4 more
May 19, 2021

Gynecologic Tumors Trial in Worldwide (Atezolizumab, Rucaparib)

Completed
  • Gynecologic Neoplasms
  • Melbourne, Victoria, Australia
  • +10 more
Oct 20, 2020

Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)

Enrolling by invitation
  • Metastatic Castration-Resistant Prostate Cancer
  • +5 more
  • Lakewood, Colorado
  • +37 more
Jan 18, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • San Francisco, California
  • +15 more
Jan 19, 2021

Solid Tumor Trial in Budapest (C-14 labeled Rucaparib, Rucaparib)

Completed
  • Solid Tumor
  • Budapest, Rottenbiller Utca 13, Hungary
    PRA Magyarország Kft.
Dec 10, 2019

Tumors Trial in Kajetany, Poznan, Szczecin (Caffeine, Warfarin, Omeprazole)

Completed
  • Neoplasms
  • Kajetany, Mokra 7, Poland
  • +2 more
Jan 6, 2020

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (Rucaparib)

Completed
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Los Angeles, California
  • +7 more
Jan 21, 2020

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +3 more
  • Denver, Colorado
  • +76 more
Feb 20, 2022

Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Concord, California
  • +73 more
Nov 9, 2023

Functional Dyspepsia Trial in Matsumoto (Acotiamide HCl hydrate, Placebo)

Recruiting
  • Functional Dyspepsia
  • Acotiamide hydrochloride hydrate
  • Placebo
  • Matsumoto, Nagano, Japan
    Zeria Investigative Site
Mar 23, 2021

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • Oral rucaparib
  • Anchorage, Alaska
  • +74 more
Jan 31, 2022

IgA Nephropathy Trial (CM338)

Not yet recruiting
  • IgA Nephropathy
  • CM338
  • (no location specified)
Mar 7, 2023

Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With

Active, not recruiting
  • COVID-19 Pneumonia
  • +4 more
    • Faro, Portugal
    • +1 more
    Apr 26, 2023

    Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib, Abiraterone acetate or Enzalutamide or Docetaxel)

    Active, not recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • Rucaparib
    • Abiraterone acetate or Enzalutamide or Docetaxel
    • Birmingham, Alabama
    • +149 more
    Jan 19, 2023

    Healthy Subjects Trial (CM338 Injection)

    Not yet recruiting
    • Healthy Subjects
    • CM338 Injection
    • (no location specified)
    May 7, 2022

    Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

    Active, not recruiting
    • Pancreatic Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 10, 2021

    Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib)

    Completed
    Has Results
    • Metastatic Castration Resistant Prostate Cancer
    • Birmingham, Alabama
    • +148 more
    Jun 14, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

    Active, not recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +6 more
    • Duarte, California
    • +8 more
    Jan 11, 2023

    Healthy Trial in Zibo (CM338, Placebo)

    Recruiting
    • Healthy
    • Zibo, Shandong, China
      PKUCare Luzhong Hospital
    Feb 10, 2022

    Tumors Trial in Poland, Slovakia, United Kingdom (Rucaparib camsylate)

    Completed
    • Neoplasms
    • Rucaparib camsylate
    • Biała Podlaska, Poland
    • +5 more
    Oct 26, 2021

    Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Worldwide (Rucaparib)

    Terminated
    Has Results
    • Bladder Cancer
    • +7 more
    • Scottsdale, Arizona
    • +63 more
    Oct 16, 2020